First Time Loading...

BiVictriX Therapeutics PLC
LSE:BVX

Watchlist Manager
BiVictriX Therapeutics PLC Logo
BiVictriX Therapeutics PLC
LSE:BVX
Watchlist
Price: 12 GBX 4.35% Market Closed
Updated: May 7, 2024

BiVictriX Therapeutics PLC
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

BiVictriX Therapeutics PLC
Cash from Financing Activities Peer Comparison

Comparables:
CNTA
AUTL
BCYC
IMCR
GNS

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
BiVictriX Therapeutics PLC
LSE:BVX
Cash from Financing Activities
£0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Cash from Financing Activities
$21.1m
CAGR 3-Years
149%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Autolus Therapeutics PLC
NASDAQ:AUTL
Cash from Financing Activities
-$883k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bicycle Therapeutics PLC
NASDAQ:BCYC
Cash from Financing Activities
$250m
CAGR 3-Years
22%
CAGR 5-Years
58%
CAGR 10-Years
N/A
Immunocore Holdings PLC
NASDAQ:IMCR
Cash from Financing Activities
£34.3m
CAGR 3-Years
-33%
CAGR 5-Years
221%
CAGR 10-Years
N/A
Genus PLC
LSE:GNS
Cash from Financing Activities
-£20.5m
CAGR 3-Years
5%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is BiVictriX Therapeutics PLC's Cash from Financing Activities?
Cash from Financing Activities
0 GBP

Based on the financial report for Dec 31, 2022, BiVictriX Therapeutics PLC's Cash from Financing Activities amounts to 0 GBP.